Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis.
D000328:Adult; D001402:B-Lymphocytes / Q000378:metabolism / Q000473:pathology; D004268:DNA-Binding Proteins / Q000235:genetics; D019254:Genes, bcl-2; D016259:Genes, myc; D020573:Genes, rel; D018740:Genetic Heterogeneity; D018858:Germinal Center / Q000473:pathology; D006801:Humans; D007121:Immunocompetence; D016867:Immunocompromised Host; D016483:Lymphoma, AIDS-Related / Q000235:genetics; D016403:Lymphoma, Large B-Cell, Diffuse / Q000145:classification / Q000235:genetics* / Q000401:mortality / Q000473:pathology / Q000628:therapy; D018396:Mucin-1 / Q000235:genetics; D009363:Neoplasm Proteins / Q000235:genetics; D011183:Postoperative Complications; D011379:Prognosis; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins / Q000235:genetics; D051560:Proto-Oncogene Proteins c-bcl-6; D011519:Proto-Oncogenes; D027041:Somatic Hypermutation, Immunoglobulin; D014157:Transcription Factors / Q000235:genetics; D014180:Transplantation
D004268:DNA-Binding Proteins; C000715470:MAS1 protein, human; D018396:Mucin-1; C106193:NBEAP1 protein, human; D009363:Neoplasm Proteins; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins; D051560:Proto-Oncogene Proteins c-bcl-6; D014157:Transcription Factors